Telix Pharmaceuticals takes an exclusive purchase option for the acquisition of Atlab Pharma

Telix Pharmaceuticals and Atlab Pharma conclude therapeutic product development agreement for prostate cancer. Telix website (EN) Press release (EN) : Telix Pharmaceuticals Limited (“Telix”) is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS (“Atlab”). Under the terms of the agreement, Telix… read more →